145 related articles for article (PubMed ID: 1863876)
21. Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules.
Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
Adv Nephrol Necker Hosp; 1994; 23():347-56. PubMed ID: 8154364
[No Abstract] [Full Text] [Related]
22. Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?
Waters TM; Bennett CL; Pajeau TS; Sobocinski KA; Klein JP; Rowlings PA; Horowitz MM
Bone Marrow Transplant; 1998 Apr; 21(7):641-50. PubMed ID: 9578302
[TBL] [Abstract][Full Text] [Related]
23. The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma.
Engert A; Sausville EA; Vitetta E
Curr Top Microbiol Immunol; 1998; 234():13-33. PubMed ID: 9670610
[TBL] [Abstract][Full Text] [Related]
24. Targeted therapy for hematologic malignancies: has its promise been realized?
Matthews DC; Appelbaum FR; Press OW; Eary JF; Bernstein ID
Curr Opin Hematol; 1995 Jul; 2(4):235-9. PubMed ID: 9372002
[No Abstract] [Full Text] [Related]
25. [Use of antibodies or their fragments for the treatment of tumors].
Douillard JY; Chatal JF
Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic, syngeneic and autologous marrow transplantation in the acute leukemias and lymphomas--Baltimore experiences.
Santos GW; Saral R; Burns WH; Braine HG; Sensenbrenner LL; Wingard JR; Yeager AM; Jones R; Ambinder RF; Rowley SD
Acta Haematol; 1987; 78 Suppl 1():175-80. PubMed ID: 3124443
[TBL] [Abstract][Full Text] [Related]
27. [Monoclonal antibodies for lymphomas and leukemias in 2005].
Peffault de Latour R; Robin M; Bay JO
Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
29. Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.
Vallera DA
Cancer Treat Res; 1988; 37():515-35. PubMed ID: 2908642
[No Abstract] [Full Text] [Related]
30. [Supralethal treatment and bone marrow autotransplantation in the treatment of patients with leukemia and malignant lymphoma].
Ernst P
Ugeskr Laeger; 1986 Aug; 148(33):2067-71. PubMed ID: 3529563
[No Abstract] [Full Text] [Related]
31. Acute leukemias, myelodysplasia, and lymphomas.
Antin JH; Rosenthal DS
Clin Geriatr Med; 1985 Nov; 1(4):795-826. PubMed ID: 3913520
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in the management of lymphomas and leukemias.
DIAMOND HD
Med Clin North Am; 1953 May; 1():843-67. PubMed ID: 13086014
[No Abstract] [Full Text] [Related]
33. Chemotherapy of the malignant lymphomas and leukemias.
GAMBLE JF
Med Ann Dist Columbia; 1962 Apr; 31():195-9. PubMed ID: 13896557
[No Abstract] [Full Text] [Related]
34. Triethylene melamine in the treatment of lymphomas and leukemias.
KARNOFSKY DA
Med Clin North Am; 1954 Mar; 11():541-54. PubMed ID: 13153527
[No Abstract] [Full Text] [Related]
35. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Strandjord SE; Warkintin PI; Cheung NK; Gordon EM; Novak L; Shina D
Semin Oncol; 1987 Jun; 14(2 Suppl 1):139-40. PubMed ID: 3296203
[No Abstract] [Full Text] [Related]
36. Targeted antibodies in the treatment of lymphomas.
Falini B; Terenzi A; Liso A; Flenghi L; Solinas A; Pasqualucci L
Cancer Surv; 1997; 30():295-309. PubMed ID: 9547998
[TBL] [Abstract][Full Text] [Related]
37. [Recent treatments for lymphomas, leukemias, and similar conditions].
CRAVER LF
Am Clin; 1948 Jun; 12(6):493-502. PubMed ID: 18869826
[No Abstract] [Full Text] [Related]
38. Use of antibodies and immunoconjugates for the therapy of more accessible cancers.
Sharkey RM; Goldenberg DM
Adv Drug Deliv Rev; 2008 Sep; 60(12):1407-20. PubMed ID: 18508155
[TBL] [Abstract][Full Text] [Related]
39. The role of immunology in the treatment of leukemias and hematosarcomas.
Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
Cancer Res; 1967 Dec; 27(12):2542-53. PubMed ID: 4170385
[No Abstract] [Full Text] [Related]
40. Marrow transplantation for malignant disease.
Thomas ED
Am J Med Sci; 1987 Aug; 294(2):75-9. PubMed ID: 3307408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
